Study: St. Jude Medical's CardioMEMS device slashes readmission rates

St. Jude Medical's CardioMEMS heart failure monitor slashes 30-day hospital readmission rates in Medicare-eligible patients, according to an analysis of data from St. Jude's Champion trial.

CardioMEMS Inc., St. Jude Medical, American Heart Assn.

News Well, Clinical Trials, Cardiovascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1F04w34